Deficits in Mitochondrial Complex I in Schizophrenia: A Possible Link to Pseudogene Regulation

被引：0
|
作者：
Ben-Shachar, Dorit [1 ]
Bergman, Oded [1 ]
Karry, Rachel [1 ]
机构：
[1] Rambam Hlth Care Campus Technion, IIT, Haifa, Israel
来源：
BIOLOGICAL PSYCHIATRY | 2018年 / 83卷 / 09期
基金：
以色列科学基金会;
关键词：
Mitochondria; Complex I; NDUFV2; NDUFV2 Pseudogene (NDUFV2P1); Schizophrenia;
D O I：
10.1016/j.biopsych.2018.02.532
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T195
引用
收藏
页码：S204 / S204
页数：1
相关论文
共 50 条
  • [21] Regulation of mitochondrial complex I by nitric oxide during hypoxia
    Galkin, Alexander S.
    Moncada, Salvador
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2008, 1777 : S53 - S53
  • [22] A Possible Link between Anxiety and Schizophrenia and a Possible Role of Anhedonia
    Grillo, Luigi
    SCHIZOPHRENIA RESEARCH AND TREATMENT, 2018, 2018
  • [23] Mitochondrial Complex I, a Possible Sensible Site of cAMP Pathway in Aging
    Signorile, Anna
    De Rasmo, Domenico
    ANTIOXIDANTS, 2023, 12 (02)
  • [24] Mitochondrial complex I inhibition as a possible mechanism of chlorpyrifos induced neurotoxicity
    Salama, Mohamed
    El-Morsy, Doaa
    El-Gamal, Mohamed
    Shabka, Osama
    Mohamed, Wael M. Y.
    ANNALS OF NEUROSCIENCES, 2014, 21 (03) : 85 - 89
  • [25] Impairments in the synthesis of the first complex of the respiratory chain as a possible cause for mitochondrial dysfunction in schizophrenia
    Bergman, O.
    Karry, R.
    Ben-Shachar, D.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2014, 53 : S18 - S19
  • [26] Contribution of dopamine to mitochondrial complex I inhibition and dopaminergic deficits caused by methylenedioxymethamphetamine in mice
    Barros-Minones, L.
    Goni-Allo, B.
    Suquia, V.
    Beitia, G.
    Aguirre, N.
    Puerta, E.
    NEUROPHARMACOLOGY, 2015, 93 : 124 - 133
  • [27] An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition
    Andrea Terron
    Anna Bal-Price
    Alicia Paini
    Florianne Monnet-Tschudi
    Susanne Hougaard Bennekou
    Marcel Leist
    Stefan Schildknecht
    Archives of Toxicology, 2018, 92 : 41 - 82
  • [28] Possible correction of neurocognitive deficits in schizophrenia patients with fluvoxamine
    Sofronov, A.
    Savelyev, A.
    Spikina, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S347 - S348
  • [29] An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition
    Terron, Andrea
    Bal-Price, Anna
    Paini, Alicia
    Monnet-Tschudi, Florianne
    Bennekou, Susanne Hougaard
    Leist, Marcel
    Schildknecht, Stefan
    ARCHIVES OF TOXICOLOGY, 2018, 92 (01) : 41 - 82
  • [30] Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia
    Rosenfeld, M.
    Brenner-Lavie, H.
    Ben-Ari, Sh.
    Kavushansky, A.
    Ben-Shachar, D.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2011, 45 (SUPPL 1) : S99 - S99
12345